Clinical Trials Browser

Phase 1 × Leukemia × talazoparib × Clear all

NCT03974217 2026-02-25

Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts

Phase 1 Active not recruiting

Other hematologic neoplasm

Leukemia